COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study
Abstract
:1. Introduction
2. Materials and Methods
2.1. Codebook
2.1.1. Position of the Comment
2.1.2. Tone of the Comment
2.2. Sampling Technique
2.3. Statistical Analysis
3. Results
3.1. Description of the Collected Data
3.2. Position of Social Media Users towards COVID-19 Vaccine
3.2.1. On the Country Level
Twitter Acceptance
3.2.2. On the Continental Level
3.3. Tone of the Social Media Comments towards COVID-19 Vaccine
3.3.1. On the Country Level
3.3.2. On the Continental Level
4. Discussion
Strength and Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19—11 March 2020. Available online: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---11-march-2020 (accessed on 25 March 2021).
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online: https://covid19.who.int/ (accessed on 25 March 2021).
- Asem, N.; Ramadan, A.; Hassany, M.; Ghazy, R.M.; Abdallah, M.; Ibrahim, M.; Gamal, E.M.; Hassan, S.; Kamal, N.; Zaid, H. Pattern and determinants of COVID-19 infection and mortality across countries: An ecological study. Heliyon 2021, 7, e07504. [Google Scholar] [CrossRef] [PubMed]
- Hassaan, M.A.; Abdelwahab, R.G.; Elbarky, T.A.; Ghazy, R.M. GIS-Based Analysis Framework to Identify the Determinants of COVID-19 Incidence and Fatality in Africa. J. Prim. Care Community Health 2021, 12, 21501327211041208. [Google Scholar] [CrossRef] [PubMed]
- Abbasi, J. Younger adults caught in COVID-19 crosshairs as demographics shift. JAMA 2020, 324, 2141–2143. [Google Scholar] [CrossRef] [PubMed]
- Lenzen, M.; Li, M.; Malik, A.; Pomponi, F.; Sun, Y.-Y.; Wiedmann, T.; Faturay, F.; Fry, J.; Gallego, B.; Geschke, A. Global socio-economic losses and environmental gains from the Coronavirus pandemic. PLoS ONE 2020, 15, e0235654. [Google Scholar] [CrossRef]
- Bundgaard, H.; Bundgaard, J.S.; Raaschou-Pedersen, D.E.T.; von Buchwald, C.; Todsen, T.; Norsk, J.B.; Pries-Heje, M.M.; Vissing, C.R.; Nielsen, P.B.; Winsløw, U.C.; et al. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial. Ann. Intern. Med. 2021, 174, 335–343. [Google Scholar] [CrossRef]
- Aschwanden, C. The false promise of herd immunity for COVID-19. Nature 2020, 587, 26–28. [Google Scholar] [CrossRef]
- Howard, J.; Huang, A.; Li, Z.; Tufekci, Z.; Zdimal, V.; van der Westhuizen, H.-M.; von Delft, A.; Price, A.; Fridman, L.; Tang, L.-H. An evidence review of face masks against COVID-19. Proc. Natl. Acad. Sci. USA 2021, 118, e2014564118. [Google Scholar] [CrossRef]
- Ghazy, R.M.; Taha, S.H.N.; Elhadi, Y.A.M. Letter from Egypt. Respirology 2022, 27, 242–244. [Google Scholar] [CrossRef]
- Talic, S.; Shah, S.; Wild, H.; Gasevic, D.; Maharaj, A.; Ademi, Z.; Li, X.; Xu, W.; Mesa-Eguiagaray, I.; Rostron, J. Effectiveness of public health measures in reducing the incidence of COVID-19, SARS-CoV-2 transmission, and COVID-19 mortality: Systematic review and meta-analysis. BMJ 2021, 375, e068302. [Google Scholar]
- Abdou, M.S.; Kheirallah, K.A.; Aly, M.O.; Ramadan, A.; Elhadi, Y.A.M.; Elbarazi, I.; Deghidy, E.A.; El Saeh, H.M.; Salem, K.M.; Ghazy, R.M. The coronavirus disease 2019 (COVID-19) vaccination psychological antecedent assessment using the Arabic 5c validated tool: An online survey in 13 Arab countries. PLoS ONE 2021, 16, e0260321. [Google Scholar] [CrossRef]
- World Health Organization. Ten Threats to Global Health in 2019. Available online: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 (accessed on 25 March 2021).
- Ghazy, R.M.; Abd ElHafeez, S.; Shaaban, R.; Elbarazi, I.; Abdou, M.S.; Ramadan, A.; Kheirallah, K.A. Determining the Cutoff Points of the 5C Scale for Assessment of COVID-19 Vaccines Psychological Antecedents among the Arab Population: A Multinational Study. J. Prim. Care Community Health 2021, 12, 21501327211018568. [Google Scholar] [CrossRef] [PubMed]
- Schuster, M.; Eskola, J.; Duclos, P. Review of vaccine hesitancy: Rationale, remit and methods. Vaccine 2015, 33, 4157–4160. [Google Scholar] [CrossRef] [PubMed]
- Abd ElHafeez, S.; Elbarazi, I.; Shaaban, R.; ElMakhzangy, R.; Ossama Aly, M.; Alnagar, A.; Yacoub, M.; El Saeh, H.M.; Eltaweel, N.; Alqutub, S.T.; et al. Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents. PLoS ONE 2021, 16, e0254595. [Google Scholar] [CrossRef] [PubMed]
- Our World in Data. Coronavirus (COVID-19) Vaccinations. Available online: https://ourworldindata.org/covid-vaccinations (accessed on 25 March 2021).
- Ghazy, R.M.; Ashmawy, R.; Hamdy, N.A.; Elhadi, Y.A.M.; Reyad, O.A.; Elmalawany, D.; Almaghraby, A.; Shaaban, R.; Taha, S.H.N. Efficacy and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Vaccines 2022, 10, 350. [Google Scholar] [CrossRef] [PubMed]
- Ashmawy, R.; Hamdy, N.A.; Elhadi, Y.A.M.; Alqutub, S.T.; Esmail, O.F.; Abdou, M.S.M.; Reyad, O.A.; El-ganainy, S.O.; Gad, B.K.; Nour El-Deen, A.E.-S.; et al. A Meta-Analysis on the Safety and Immunogenicity of COVID-19 Vaccines. J. Prim. Care Community Health 2022, 13, 21501319221089255. [Google Scholar] [CrossRef]
- Andrews, N.; Tessier, E.; Stowe, J.; Gower, C.; Kirsebom, F.; Simmons, R.; Gallagher, E.; Thelwall, S.; Groves, N.; Dabrera, G. Duration of Protection against Mild and Severe Disease by COVID-19 Vaccines. New Engl. J. Med. 2022, 386, 340–350. [Google Scholar] [CrossRef]
- Scobie, H.M.; Johnson, A.G.; Suthar, A.B.; Severson, R.; Alden, N.B.; Balter, S.; Bertolino, D.; Blythe, D.; Brady, S.; Cadwell, B. Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status—13 US jurisdictions, April 4–July 17, 2021. Morb. Mortal. Wkly. Rep. 2021, 70, 1284. [Google Scholar] [CrossRef]
- Bullock, J.; Lane, J.E.; Shults, F.L. What causes COVID-19 vaccine hesitancy? Ignorance and the lack of bliss in the United Kingdom. Humanit. Soc. Sci. Commun. 2022, 9, 1–7. [Google Scholar] [CrossRef]
- Dhama, K.; Sharun, K.; Tiwari, R.; Dhawan, M.; Emran, T.B.; Rabaan, A.A.; Alhumaid, S. COVID-19 vaccine hesitancy–reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic. Hum. Vaccines Immunother. 2021, 17, 3495–3499. [Google Scholar] [CrossRef]
- Pool, J.; Fatehi, F.; Akhlaghpour, S. Infodemic, misinformation and disinformation in pandemics: Scientific landscape and the road ahead for public health informatics research. In Public Health and Informatics; IOS Press: Amsterdam, The Netherlands, 2021; pp. 764–768. [Google Scholar]
- Ball, P.; Maxmen, A. The epic battle against coronavirus misinformation and conspiracy theories. Nature 2020, 581, 371–375. [Google Scholar] [CrossRef]
- Siddiquea, B.N.; Shetty, A.; Bhattacharya, O.; Afroz, A.; Billah, B. Global epidemiology of COVID-19 knowledge, attitude and practice: A systematic review and meta-analysis. BMJ Open 2021, 11, e051447. [Google Scholar] [CrossRef] [PubMed]
- Coe, K.; Scacco, J.M. Content Analysis, Quantitative. In The International Encyclopedia of Communication Research Methods; Wiley: Hoboken, NJ, USA, 2017; pp. 1–11. [Google Scholar]
- Statista. The Statistics Portal for Market Data, Market Research and Market Studies. Available online: https://www.statista.com (accessed on 25 March 2021).
- Cole, F.L. Content analysis: Process and application. Clin. Nurse Spec. 1988, 2, 53–57. [Google Scholar] [CrossRef] [PubMed]
- Riff, D.; Lacy, S.; Fico, F. Analyzing Media Messages: Using Quantitative Content Analysis in Research; Routledge: London, UK, 2014. [Google Scholar]
- Ventola, C.L. Social media and health care professionals: Benefits, risks, and best practices. Pharm. Ther. 2014, 39, 491. [Google Scholar]
- Aschwanden, C. Five reasons why COVID herd immunity is probably impossible. Nature 2021, 591, 520–522. [Google Scholar] [CrossRef]
- Germani, F.; Biller-Andorno, N. The anti-vaccination infodemic on social media: A behavioral analysis. PLoS ONE 2021, 16, e0247642. [Google Scholar] [CrossRef]
- Muric, G.; Wu, Y.; Ferrara, E. COVID-19 Vaccine Hesitancy on Social Media: Building a Public Twitter Data Set of Antivaccine Content, Vaccine Misinformation, and Conspiracies. JMIR Public Health Surveill. 2021, 7, e30642. [Google Scholar] [CrossRef]
- Bono, S.A.; Faria de Moura Villela, E.; Siau, C.S.; Chen, W.S.; Pengpid, S.; Hasan, M.T.; Sessou, P.; Ditekemena, J.D.; Amodan, B.O.; Hosseinipour, M.C.; et al. Factors Affecting COVID-19 Vaccine Acceptance: An International Survey among Low- and Middle-Income Countries. Vaccines 2021, 9, 515. [Google Scholar] [CrossRef]
- Roy, D.N.; Biswas, M.; Islam, E.; Azam, M.S. Potential factors influencing COVID-19 vaccine acceptance and hesitancy: A systematic review. PLoS ONE 2022, 17, e0265496. [Google Scholar] [CrossRef]
- Nuzhath, T.; Tasnim, S.; Sanjwal, R.K.; Trisha, N.F.; Rahman, M.; Mahmud, S.F.; Arman, A.; Chakraborty, S.; Hossain, M.M. COVID-19 vaccination hesitancy, misinformation and conspiracy theories on social media: A content analysis of Twitter data. SocArXiv 2020, 7, 11. [Google Scholar] [CrossRef]
- Griffith, J.; Marani, H.; Monkman, H. COVID-19 vaccine hesitancy in Canada: Content analysis of tweets using the theoretical domains framework. J. Med. Internet Res. 2021, 23, e26874. [Google Scholar] [CrossRef]
- Meleo-Erwin, Z.; Basch, C.; MacLean, S.A.; Scheibner, C.; Cadorett, V. “To each his own”: Discussions of vaccine decision-making in top parenting blogs. Hum. Vaccines Immunother. 2017, 13, 1895–1901. [Google Scholar] [CrossRef] [PubMed]
- Oehler, R.L. On measles, vaccination, social media activism, and how to win back our role as our patients’ best advocates. Clin. Infect. Dis. 2020, 70, 338–340. [Google Scholar] [CrossRef] [PubMed]
- Ortiz, R.R.; Smith, A.; Coyne-Beasley, T. A systematic literature review to examine the potential for social media to impact HPV vaccine uptake and awareness, knowledge, and attitudes about HPV and HPV vaccination. Hum. Vaccines Immunother. 2019, 15, 1465–1475. [Google Scholar] [CrossRef] [PubMed]
- Callender, D. Vaccine hesitancy: More than a movement. Hum. Vaccines Immunother. 2016, 12, 2464–2468. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jones, A.M.; Omer, S.B.; Bednarczyk, R.A.; Halsey, N.A.; Moulton, L.H.; Salmon, D.A. Parents’ source of vaccine information and impact on vaccine attitudes, beliefs, and nonmedical exemptions. Adv. Prev. Med. 2012, 2012, 932741. [Google Scholar] [CrossRef]
- Jones, D.G. Religious Concerns about COVID-19 Vaccines: From Abortion to Religious Freedom. J. Relig. Health 2022, 1–20. [Google Scholar] [CrossRef]
- Elbarazi, I.; Saddik, B.; Grivna, M.; Aziz, F.; Elsori, D.; Stip, E.; Bendak, E. The Impact of the COVID-19 “Infodemic” on Well-Being: A Cross-Sectional Study. J. Multidiscip. Healthc. 2022, 15, 289. [Google Scholar] [CrossRef]
- Farooq, F.; Rathore, F.A. COVID-19 Vaccination and the Challenge of Infodemic and Disinformation. J. Korean Med. Sci. 2021, 36, e78. [Google Scholar] [CrossRef]
- Wawrzuta, D.; Jaworski, M.; Gotlib, J.; Panczyk, M. What Arguments against COVID-19 Vaccines Run on Facebook in Poland: Content Analysis of Comments. Vaccines 2021, 9, 481. [Google Scholar] [CrossRef]
- Lyu, J.C.; Han, E.L.; Luli, G.K. COVID-19 Vaccine-Related Discussion on Twitter: Topic Modeling and Sentiment Analysis. J. Med. Internet Res. 2021, 23, e24435. [Google Scholar] [CrossRef]
Facebook (n = 4897) | With Vaccination (n = 1975) | Against Vaccination (n = 2124) | Neutral (n = 798) | p * | |
---|---|---|---|---|---|
Country | Brazil | 393 (67.5) | 126 (21.6) | 63 (10.8) | <0.001 |
Egypt | 176 (48.5) | 122 (33.6) | 65 (17.9) | ||
Germany | 133 (38.2) | 184 (52.9) | 31 (8.9) | ||
Iraq | 43 (56.6) | 27 (35.5) | 6 (7.9) | ||
Jordan | 5 (8.5) | 53 (89.8) | 1 (1.7) | ||
Kuwait | 15 (65.2) | 5 (21.7) | 3 (13.0) | ||
Libya | 15 (75.0) | 5 (25.0) | 0 (0.0) | ||
Malaysia | 102 (33.2) | 123 (40.1) | 82 (26.7) | ||
Mexico | 24 (22.6) | 22 (20.8) | 60 (56.6) | ||
Myanmar | 57 (57.0) | 4 (4.0) | 39 (39.0) | ||
Oman | 3 (15.0) | 1 (5.0) | 16 (80.0) | ||
Palestine | 11 (24.4) | 25 (55.6) | 9 (20.0) | ||
Portugal | 31 (49.2) | 23 (36.5) | 9 (14.3) | ||
Saudi Arabia | 303 (88.3) | 33 (9.6) | 7 (2.0) | ||
Senegal | 1 (20.0) | 3 (60.0) | 1 (20.0) | ||
Sudan | 4 (40.0) | 6 (60.0) | 0 (0.0.) | ||
Sweden | 40 (72.7) | 11 (20.0) | 4 (7.3) | ||
Thailand | 44 (50.6) | 5 (5.7) | 38 (43.7) | ||
Tunisia | 22 (61.1) | 14 (38.9) | 0 (0.0) | ||
UAE | 70 (76.1) | 3 (3.3) | 19 (20.7) | ||
UK | 59 (21.9) | 200 (74.3) | 10 (3.7) | ||
USA | 393 (22.6) | 1049 (60.4) | 296 (17.0) | ||
Morocco | 31 (20.7) | 80 (53.3) | 39 (26.0) | ||
Twitter (n = 965) | With vaccination (n = 400) | Against vaccination (n = 515) | Neutral (n = 50) | p | |
Country | Brazil | 214 (81.1) | 40 (15.2) | 10 (3.8) | <0.001 |
Egypt | 8 (44.4) | 9 (50.0) | 1 (5.6) | ||
Germany | 19 (47.5) | 17 (42.5) | 4 (10.0) | ||
Kuwait | 4 (80.0) | 1 (20.0) | 0 (0.0) | ||
Lebanon | 11 (84.6) | 1 (7.7) | 1 (7.7) | ||
Oman | 1 (14.3) | 1 (14.3) | 5 (71.4) | ||
Portugal | 2 (66.7) | 0 (0.0) | 1 (33.3) | ||
Saudi Arabia | 16 (38.1) | 13 (31.0) | 13 (31.0) | ||
Sudan | 0 (0.0) | 1 (100.0) | 0 (0.0) | ||
UAE * | 5 (100.0) | 0 (0.0) | 0 (0.0) | ||
UK * | 30 (23.3) | 93 (72.1) | 6 (4.7) | ||
USA * | 90 (20.5) | 339 (77.4) | 9 (2.1) |
Comment Position | p | |||||
Total (n = 4897) | With Vaccination (n = 1975) | Against Vaccination (n = 2124) | Neutral (n = 798) | |||
Continents | Africa | 584 | 249 (42.6) | 230 (39.4) | 105 (18.0) | <0.001 |
Asia | 1152 | 653 (56.7) | 279 (24.2) | 220 (19.1) | ||
Europe | 735 | 263 (35.8) | 418 (56.9) | 54 (7.3) | ||
North America | 1844 | 417 (22.6) | 1071 (58.1) | 356 (19.3) | ||
South America | 582 | 393 (67.5) | 126 (21.6) | 63 (10.8) | ||
Total (n = 965) | With Vaccination (n = 400) | Against Vaccination (n = 515) | Neutral (n = 50) | p | ||
Continents | Africa | 19 | 8 (42.1) | 10 (52.6) | 1 (5.3) | <0.001 |
Asia | 72 | 37 (51.4) | 16 (22.2) | 19 (26.4) | ||
Europe | 172 | 51 (29.7) | 110 (64.0) | 11 (6.4) | ||
North America | 438 | 90 (20.5) | 339 (77.4) | 9 (2.1) | ||
South America | 264 | 214 (81.1) | 40 (15.2) | 10 (3.8) |
Facebook (n = 4897) | Humorous (n = 1927) | Sarcastic (n = 190) | Opinion (n = 616) | Serious (n = 2164) | p | |
Country | Brazil | 269 (46.2) | 23 (4.0) | 31 (5.3) | 259 (44.5) | <0.001 |
Egypt | 180 (49.6) | 28 (7.7) | 84 (23.1) | 71 (19.6) | ||
Germany | 96 (27.60) | 13 (3.7) | 73 (21.0) | 166 (47.7) | ||
Iraq | 53 (69.7) | 9 (11.8) | 14 (18.4) | 0 (0.0) | ||
Jordan | 19 (32.2) | 4 (6.8) | 22 (37.3) | 14 (23.7) | ||
Kuwait | 14)60.9) | 0 (0.0) | 1 (4.3) | 8 (34.8) | ||
Libya | 15 (75.0) | 0 (0.0) | 4 (20.0) | 1 (5.0) | ||
Malaysia | 164 (53.4) | 20 (6.5) | 12 (3.9) | 111 (36.2) | ||
Mexico | 38 (35.8) | 7 (6.6) | 26 (25.4) | 35 (33.0) | ||
Myanmar | 50 (50.0) | 4 (4.0) | 8 (8.0) | 38 (38.0) | ||
Oman | 19 (95.0) | 0 (0.0) | 0 (0.0) | 1 (5.0) | ||
Palestine | 16 (35.6) | 1 (2.2) | 4 (8.9) | 24 (53.3) | ||
Portugal | 43 (69.3) | 1 (1.6) | 9 (14.3) | 10 (15.9) | ||
Saudi Arabia | 215 (62.7) | 5 (1.5) | 9 (2.6) | 114 (33.2) | ||
Senegal | 1 (20.0) | 0 (0.0) | 2 (40.0) | 2 (40.0) | ||
Sudan | 5 (50.0) | 2 (20.0) | 3 (30.0) | 0 (0.0) | ||
Sweden | 4 (7.3) | 1 (1.8) | 0 (0.0) | 50 (90.9) | ||
Thailand | 31 (35.6) | 4 (4.6) | 1 (1.1) | 51 (58.6) | ||
Tunisia | 22 (61.1) | 6 (16.7) | 6 (16.7) | 2 (5.6) | ||
UAE | 92 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||
UK | 105 (39.0) | 17 (6.3) | 80 (29.7) | 67 (24.9) | ||
USA | 429 (24.7) | 38 (2.2) | 205 (11.8) | 1066 (61.3) | ||
Morocco | 47 (31.3) | 7 (4.7) | 22 (14.7) | 74 (49.3) | ||
Humorous (n = 46) | Sarcastic (n = 167) | Opinion (n = 317) | Serious (n = 435) | p | ||
Country | Brazil | 35 (13.3) | 11 (4.2) | 191 (72.3) | 27 (10.2) | <0.001 |
Egypt | 0 (0.0) | 2 (11.1) | 3 (16.7) | 13 (72.2) | ||
Germany | 0 (0.0) | 14 (35.0) | 9 (22.5) | 17 (42.5) | ||
Kuwait | 0 (0.0) | 1 (20.0) | 3 (60.0) | 1 (20.0) | ||
Lebanon | 0 (0.0) | 1 (7.7) | 11 (84.6) | 1 (7.7) | ||
Oman | 0 (0.0) | 0 (0.0) | 7 (100.0) | 0 (0.0) | ||
Portugal | 0 (0.0) | 0 (0.0) | 3 (100.0) | 0 (0.0) | ||
Saudi Arabia | 0 (0.0) | 6 (14.3) | 17 (40.5) | 19 (45.2) | ||
Sudan | 0 (0.0) | 0 (0.0) | 1 (100.0) | 0 (0.0) | ||
UAE * | 0 (0.0) | 0 (0.0) | 5 (100.0) | 0 (0.0) | ||
UK * | 8 (6.2) | 38 (29.5) | 68 (52.7) | 15 (11.6) | ||
USA * | 3 (0.7) | 94 (21.5) | 117 (26.7) | 224 (51.1) |
Total (n = 4897) | Serious (n = 1927) | Humorous (n = 190) | Sarcastic (n = 616) | Opinion (n = 2164) | p * | ||
Continents | Africa | 584 | 270 (46.2) | 43 (7.4) | 121 (20.7) | 150 (25.7) | <0.001 |
Asia | 1152 | 673 (58.4) | 47 (4.1) | 71 (6.2) | 361 (31.3) | ||
Europe | 735 | 248 (33.7) | 32 (4.4) | 162 (22.0) | 293 (39.9) | ||
North America | 1844 | 467 (25.3) | 45 (2.4) | 231 (12.5) | 1101 (59.7) | ||
South America | 582 | 269 (46.2) | 23 (4.0) | 31 (5.3) | 259 (44.5) | ||
Comment Tone | p | ||||||
Total (n = 965) | Serious (n = 435) | Humorous (n = 46) | Sarcastic (n = 167) | Opinion (n = 317) | |||
Continents | Africa | 19 | 4 (21.1) | 0 (0.0) | 2 (10.5) | 13 (68.4) | p < 0.001 |
Asia | 72 | 43 (59.7) | 0 (0.0) | 8 (11.1) | 21 (29.2) | ||
Europe | 172 | 80 (46.5) | 8 (4.7) | 52 (30.2) | 32 (18.6) | ||
North America | 438 | 117 (26.7) | 3 (0.7) | 94 (21.5) | 224 (51.1) | ||
South America | 264 | 191 (72.3) | 35 (13.3) | 11 (4.2) | 27 (10.2) |
Comment Tone | p | |||||
---|---|---|---|---|---|---|
Serious | Humorous | Sarcastic | Opinion | |||
Comment Position | With | 1275 (53.7) | 76 (3.2) | 97 (4.1) | 927 (39.0) | p < 0.001 |
Against | 732 (27.7) | 119 (4.5) | 592 (22.4) | 1196 (45.3 | ||
Neutral | 355 (41.9) | 41 (4.8) | 94 (11.1) | 358 (42.2) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Shaaban, R.; Ghazy, R.M.; Elsherif, F.; Ali, N.; Yakoub, Y.; Aly, M.O.; ElMakhzangy, R.; Abdou, M.S.; McKinna, B.; Elzorkany, A.M.; et al. COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study. Int. J. Environ. Res. Public Health 2022, 19, 5737. https://doi.org/10.3390/ijerph19095737
Shaaban R, Ghazy RM, Elsherif F, Ali N, Yakoub Y, Aly MO, ElMakhzangy R, Abdou MS, McKinna B, Elzorkany AM, et al. COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study. International Journal of Environmental Research and Public Health. 2022; 19(9):5737. https://doi.org/10.3390/ijerph19095737
Chicago/Turabian StyleShaaban, Ramy, Ramy Mohamed Ghazy, Fawzia Elsherif, Nancy Ali, Youssef Yakoub, Maged Osama Aly, Rony ElMakhzangy, Marwa Shawky Abdou, Bonny McKinna, Amira Mohamed Elzorkany, and et al. 2022. "COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study" International Journal of Environmental Research and Public Health 19, no. 9: 5737. https://doi.org/10.3390/ijerph19095737
APA StyleShaaban, R., Ghazy, R. M., Elsherif, F., Ali, N., Yakoub, Y., Aly, M. O., ElMakhzangy, R., Abdou, M. S., McKinna, B., Elzorkany, A. M., Abdullah, F., Alnagar, A., ElTaweel, N., Alharthi, M., Mohsin, A., Ordóñez-Cruickshank, A., Toniolo, B., Grafolin, T., Aye, T. T., ... Kamal, A. (2022). COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study. International Journal of Environmental Research and Public Health, 19(9), 5737. https://doi.org/10.3390/ijerph19095737